Open Orphan Plc (LON:ORPH – Get Free Report)’s share price traded up 5.3% during mid-day trading on Monday . The company traded as high as GBX 10.38 ($0.14) and last traded at GBX 10 ($0.13). 652,639 shares changed hands during mid-day trading, a decline of 58% from the average session volume of 1,559,247 shares. The stock had previously closed at GBX 9.50 ($0.12).
Open Orphan Stock Performance
The stock has a market cap of £67.09 million and a P/E ratio of -25.30. The company has a debt-to-equity ratio of 10.88, a quick ratio of 1.16 and a current ratio of 1.19. The firm’s 50 day moving average is GBX 10 and its 200 day moving average is GBX 10.
About Open Orphan
Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Featured Stories
- Five stocks we like better than Open Orphan
- Best Stocks Under $10.00
- Why Block’s Key Components Make It a Solid Investment Choice
- Why Invest in High-Yield Dividend Stocks?
- Is Applied Digital’s Stock Set to Surge With NVIDIA’s Backing?
- CD Calculator: Certificate of Deposit Calculator
- 4 Reasons to Consider Adding General Mills to Your Portfolio
Receive News & Ratings for Open Orphan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Open Orphan and related companies with MarketBeat.com's FREE daily email newsletter.